FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/06/2026
Back to search
Official data from USPTO
XERVYTEG
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
08/06/2026
Trademark type
Word
Nice classes
5, 10
Filing date
03/21/2025
Registration date
01/27/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2026
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
GLUECK, CHRISTOPHER N
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
M. P. (pessoa física)
Representatives
Pina M. Campagna Carter, DeLuca, & Farrell, LLP
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and biopharmaceutical products and preparations for the medical treatment of gastrointestinal diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical products and preparations used for the treatment of cancersneurological diseasespsychiatric diseasesgastrointestinal diseasesmetabolic diseasesinflammatory diseasesautoimmune diseasesinfectious diseases; pharmaceuticals used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial communityfor the treatment of dysbiosiscancersneurological diseasespsychiatric diseasesgastrointestinal diseasesmetabolic diseasesinflammatory diseasesautoimmune diseasesinfectious diseases; biological preparations in the nature of microorganisms used to maintain health or restore health to a human subject in the field of treatment of a disturbed microbial communityfor the treatment of dysbiosiscancersneurological diseasespsychiatric diseasesgastrointestinal diseasesmetabolic diseasesinflammatory diseasesautoimmune diseasesinfectious diseases
Class 10
Medical and surgical apparatus and instruments for use in gastrointestinal surgery; drug delivery devices in the nature of medical apparatus and instruments for administration of pharmaceutical and biopharmaceutical products and preparationsa kit comprising a suspension bag and administration tube setsold empty; Drug delivery devices to treat gut microbiome-related disorderscancersneurological diseasespsychiatric diseasesgastrointestinal diseasesmetabolic diseasesinflammatory diseasesautoimmune diseasesinfectious diseasessyringesinfusion setsimplantable devices sold empty; drug delivery devices to treat gut microbiome-related disorderscancersneurological diseasespsychiatric diseasesgastrointestinal diseasesmetabolic diseasesinflammatory diseasesautoimmune diseasesinfectious diseasesin the nature of a kit comprising a prefilled suspension bag and administration tube set sold without medication
Publications
History of USPTO decisions and trademark events.
29 publications found
FIMP
FINAL DISPOSITION PROCESSED
08/06/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/27/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2026
GPNX
NOTIFICATION PROCESSED BY IB
12/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/09/2025
PUBO
PUBLISHED FOR OPPOSITION
12/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/26/2025
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/25/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
11/12/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/12/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
11/12/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/29/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/29/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/29/2025
RFNT
REFUSAL PROCESSED BY IB
08/30/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/08/2025
RFRR
REFUSAL PROCESSED BY MPU
08/07/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/21/2025
CNRT
NON-FINAL ACTION WRITTEN
06/20/2025
DOCK
ASSIGNED TO EXAMINER
06/18/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/22/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/22/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/15/2025
Continuous trademark protection
Get notified about every new filing that threatens XERVYTEG or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.